Xylutide 40 mg (Enzalutamide)

Xylutide 40 mg, containing Enzalutamide, is a targeted oral therapy for treating advanced prostate cancer, especially in cases resistant to hormone therapy.

pack size Price Add to Cart
28 Capsules - USD $7.86/ Capsule$220.00
View Cart
56 Capsules - USD $7.32/ Capsule$410.00
View Cart
84 Capsules - USD $6.90/ Capsule$580.00
View Cart

Xylutide 40 mg (Enzalutamide)

Active IngredientEnzalutamide
ManufacturersCipla Limited
IndicationsProstate cancer
Strength40mg
Packaging4 capsules in 1 strip
Delivery Time6 To 15 days

Xylutide 40 mg contains Enzalutamide, a powerful androgen receptor inhibitor used in the treatment of advanced prostate cancer. It is primarily prescribed to patients with metastatic castration-resistant prostate cancer (mCRPC) or non-metastatic CRPC, especially when hormone therapy or surgical castration is no longer effective.

Enzalutamide works by blocking the effect of androgens (male hormones like testosterone) that fuel the growth of prostate cancer cells. Xylutide 40 mg is taken orally and is often used as a part of a long-term treatment plan under an oncologist’s supervision.

Important: Always take Enzalutamide exactly as prescribed. Regular medical check-ups, including blood tests and monitoring of side effects, are crucial during treatment.

pack size

28 Capsules – USD $7.86/ Capsule, 56 Capsules – USD $7.32/ Capsule, 84 Capsules – USD $6.90/ Capsule

There are no reviews yet.

Be the first to review “Xylutide 40 mg (Enzalutamide)”